These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 20717830

  • 1. Suppression of TGF-β1/SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid.
    Hsu YC, Chen MJ, Yu YM, Ko SY, Chang CC.
    Arch Dermatol Res; 2010 Dec; 302(10):717-24. PubMed ID: 20717830
    [Abstract] [Full Text] [Related]

  • 2. Induction of TIMP-1 and HSP47 synthesis in primary keloid fibroblasts by exogenous nitric oxide.
    Hsu YC, Wang LF, Chien YW, Lee WR.
    J Dermatol Sci; 2007 Jan; 45(1):37-44. PubMed ID: 17145168
    [Abstract] [Full Text] [Related]

  • 3. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
    Wu CS, Wu PH, Fang AH, Lan CC.
    Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
    [Abstract] [Full Text] [Related]

  • 4. Serum deprivation protein response intervenes in the proliferation, motility, and extracellular matrix production in keloid fibroblasts by blocking the amplification of TGF-β1/SMAD signal cascade via ERK1/2.
    Li P, Han M, Wang L, Gao C.
    Toxicol Appl Pharmacol; 2024 Aug; 489():117012. PubMed ID: 38906511
    [Abstract] [Full Text] [Related]

  • 5. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
    He S, Yang Y, Liu X, Huang W, Zhang X, Yang S, Zhang X.
    Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts.
    He S, Liu X, Yang Y, Huang W, Xu S, Yang S, Zhang X, Roberts MS.
    Br J Dermatol; 2010 Mar; 162(3):538-46. PubMed ID: 19772524
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effects of interferon-gamma on the transforming growth factor beta/Smad pathway in keloid-derived fibroblasts].
    Liu JQ, Hu DH, Zhang ZF, Guan H, She T, Zhang J, Bai XZ.
    Zhonghua Shao Shang Za Zhi; 2009 Dec; 25(6):454-9. PubMed ID: 20193171
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
    Ma HL, Zhao XF, Chen GZ, Fang RH, Zhang FR.
    Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969
    [Abstract] [Full Text] [Related]

  • 11. Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways.
    Wang W, Qu M, Xu L, Wu X, Gao Z, Gu T, Zhang W, Ding X, Liu W, Chen YL.
    J Mol Med (Berl); 2016 Oct; 94(10):1181-1194. PubMed ID: 27339758
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of transforming growth factor-beta/Smad signaling between normal dermal fibroblasts and fibroblasts derived from central and peripheral areas of keloid lesions.
    Tsujita-Kyutoku M, Uehara N, Matsuoka Y, Kyutoku S, Ogawa Y, Tsubura A.
    In Vivo; 2005 Oct; 19(6):959-63. PubMed ID: 16277007
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration.
    Fujiwara M, Muragaki Y, Ooshima A.
    Br J Dermatol; 2005 Aug; 153(2):295-300. PubMed ID: 16086739
    [Abstract] [Full Text] [Related]

  • 17. Knockdown of FOXM1 inhibits activation of keloid fibroblasts and extracellular matrix production via inhibition of TGF-β1/Smad pathway.
    Zhang Y, Cheng C, Wang S, Xu M, Zhang D, Zeng W.
    Life Sci; 2019 Sep 01; 232():116637. PubMed ID: 31288014
    [Abstract] [Full Text] [Related]

  • 18. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars.
    Zhang ZF, Zhang YG, Hu DH, Shi JH, Liu JQ, Zhao ZT, Wang HT, Bai XZ, Cai WX, Zhu HY, Tang CW.
    Burns; 2011 Jun 01; 37(4):665-72. PubMed ID: 21236582
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. TGF-ß1 antisense impacts the SMAD signalling system in fibroblasts from keloid scars.
    Bran GM, Sommer UJ, Goessler UR, Hörmann K, Riedel F, Sadick H.
    Anticancer Res; 2010 Sep 01; 30(9):3459-63. PubMed ID: 20944123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.